If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Alba Di Pardo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Huntington Disease Medicine & Life Sciences
Neurodegenerative Diseases Medicine & Life Sciences
Blood-Brain Barrier Medicine & Life Sciences
Corpus Callosum Medicine & Life Sciences
G(M1) Ganglioside Medicine & Life Sciences
Corpus Striatum Medicine & Life Sciences
Sphingolipids Medicine & Life Sciences
Brain Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2019

Curcumin C3 complex®/Bioperine® has antineoplastic activity in mesothelioma: an in vitro and in vivo analysis

Di Meo, F., Filosa, S., Madonna, M., Giello, G., Di Pardo, A., Maglione, V., Baldi, A. & Crispi, S., Aug 16 2019, In : Journal of experimental & clinical cancer research : CR. 38, 1, p. 360

Research output: Contribution to journalArticle

Curcumin
Mesothelioma
Antineoplastic Agents
Heterografts
piperine

Curcumin dietary supplementation ameliorates disease phenotype in an animal model of Huntington's disease

Elifani, F., Amico, E., Pepe, G., Capocci, L., Castaldo, S., Rosa, P., Montano, E., Pollice, A., Madonna, M., Filosa, S., Calogero, A., Maglione, V., Crispi, S. & Di Pardo, A., Oct 20 2019, In : Human Molecular Genetics.

Research output: Contribution to journalArticle

Curcumin
Huntington Disease
Dietary Supplements
Animal Models
Phenotype

Stimulation of Sphingosine Kinase 1 (SPHK1) Is Beneficial in a Huntington's Disease Pre-clinical Model

Di Pardo, A., Pepe, G., Castaldo, S., Marracino, F., Capocci, L., Amico, E., Madonna, M., Giova, S., Jeong, S. K., Park, B-M., Park, B. D. & Maglione, V., 2019, In : Frontiers in Molecular Neuroscience. 12, p. 100

Research output: Contribution to journalArticle

Huntington Disease
Therapeutics
Poisons
Disease Progression
sphingosine kinase

Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease (Scientific Reports DOI: 10.1038/s41598-017-05709-y)

Di Pardo, A., Amico, E., Basit, A., Armirotti, A., Joshi, P., Neely, M. D., Vuono, R., Castaldo, S., Digilio, A. F., Scalabrì, F., Pepe, G., Elifani, F., Madonna, M., Jeong, S. K., Park, B. M., D'Esposito, M., Bowman, A. B., Barker, R. A. & Maglione, V., Dec 1 2018, In : Scientific Reports. 8, 1, 8266.

Research output: Contribution to journalComment/debate

Huntington Disease
sphingosine 1-phosphate

New Therapeutic Drugs from Bioactive Natural Molecules: The Role of Gut Microbiota Metabolism in Neurodegenerative Diseases

Di Meo, F., Donato, S., Di Pardo, A., Maglione, V., Filosa, S. & Crispi, S., 2018, In : Current Drug Metabolism. 19, 6, p. 478-489 12 p.

Research output: Contribution to journalReview article

Neurodegenerative diseases
Metabolism
Neurodegenerative Diseases
Brain
Molecules